BA
EXAS

Boston Advisors’s Exact Sciences EXAS Stock Holding History

Boston Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.44M Buy
27,000
+10,304
+62% +$1.17M 0.13% 216
2019
Q2 		$1.97M Buy
+16,696
New +$1.68M 0.11% 222

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Boston Advisors's EXAS Position: Q3 2019 in Review

Boston Advisors increased its Exact Sciences (EXAS) stake by 62% in Q3 2019, buying an estimated $1.17M and bringing the position to 27,000 shares worth $2.44M. The position accounts for 0.13% of the portfolio, ranked #216.

Boston Advisors first reported a position in EXAS in Q2 2019 and has held it in 2 quarters since. 474 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

  • Boston Advisors held 27,000 shares of Exact Sciences worth $2.44M as of Q3 2019.
  • Boston Advisors bought 10,304 Exact Sciences shares in Q3 2019, an estimated $1.17M.
  • Exact Sciences made up 0.13% of Boston Advisors's portfolio in Q3 2019, its #216 holding.
  • Boston Advisors first reported a position in Exact Sciences in Q2 2019 and has held it in 2 quarters since.
  • 474 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.